Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30

Recall Number: D-0871-2023

Firm: Amring Pharmaceuticals Inc

Classification: Class III

Status: Terminated

Report Date: 20230621

Initiation Date: 20230612

Termination Date: 20240529

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Product Description

Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30

DrugLabelsHub provides FDA drug labeling information for reference only. Always consult a healthcare professional.

Data source: openFDA · Updated regularly